Tokyo Tape
Sign in
← Stella Pharma

Quarterly report · Q2

4888.TEDINET S100PMOE
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥92m2022-04-01 → 2022-09-30StandaloneNet sales
Revenue¥100m2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥69m2021-04-01 → 2021-09-30StandaloneNet sales
Operating income−¥367m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income−¥338m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥342m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥764m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥407m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax−¥342m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥407m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income−¥344m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income−¥768m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income−¥409m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥4.4bnat 2022-09-30StandaloneAssets
Total assets¥4.7bnat 2022-03-31StandaloneAssets
Total assets¥5.1bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥1.6bnat 2022-09-30StandaloneLiabilities
Total liabilities¥1.6bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥2.7bnat 2022-09-30StandaloneNet assets
Net assets / equity¥3.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥3.4bnat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥2.8bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥3.3bnat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥2.8bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥4.1bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥838mat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥358m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥607m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥24m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥351m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥42m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥80m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥3.8bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.9bn2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-122022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-5.132022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-27.342021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-14.852021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.492021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio62.8%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio65.3%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio67.1%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued28,676,100at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued28,676,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,646,700at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 399
ItemContextValueUnit
Decrease increase in consumption taxes refund receivable ope cfCurrentYTDDuration_NonConsolidatedMember50588000JPY
Decrease increase in other assets ope cfPrior1YTDDuration_NonConsolidatedMember13931000JPY
Decrease increase in other assets ope cfCurrentYTDDuration_NonConsolidatedMember7480000JPY
Increase decrease in other liabilities ope cfPrior1YTDDuration_NonConsolidatedMember-27134000JPY
Increase decrease in other liabilities ope cfCurrentYTDDuration_NonConsolidatedMember-23516000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember-604416000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember-354547000JPY
Interest income received ope cfPrior1YTDDuration_NonConsolidatedMember1000JPY
Interest income received ope cfCurrentYTDDuration_NonConsolidatedMember1610000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration_NonConsolidatedMember-1617000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember-1391000JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-938000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-3630000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration_NonConsolidatedMember-606970000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember-357958000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration_NonConsolidatedMember-41574000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration_NonConsolidatedMember-20169000JPY
Purchase of intangible assets inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Purchase of intangible assets inv cfCurrentYTDDuration_NonConsolidatedMember-3925000JPY
Payments for lease deposits inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Payments for lease deposits inv cfCurrentYTDDuration_NonConsolidatedMember-10000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration_NonConsolidatedMember-41574000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration_NonConsolidatedMember-24104000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember-80004000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember-80004000JPY
Proceeds from issuance of common stock fin cfPrior1YTDDuration_NonConsolidatedMember3601850000JPY
Proceeds from issuance of common stock fin cfCurrentYTDDuration_NonConsolidatedMember－JPY
Net increase decrease in restrictions on bank deposit withdrawals fin cfPrior1YTDDuration_NonConsolidatedMember372547000JPY
Net increase decrease in restrictions on bank deposit withdrawals fin cfCurrentYTDDuration_NonConsolidatedMember57000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration_NonConsolidatedMember3894393000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember-79946000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember3245847000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-462008000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember837952000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember3235502000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember4083800000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember2773493000JPY
Retirement benefit expenses sgaPrior1YTDDuration_NonConsolidatedMember3231000JPY
Retirement benefit expenses sgaCurrentYTDDuration_NonConsolidatedMember4024000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember130633000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember119863000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)近畿財務局長
Filing date cover pageFilingDateInstant2022-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第16期第２四半期（自　2022年７月１日　至　2022年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)ステラファーマ株式会社
Company name in english cover pageFilingDateInstantSTELLA PHARMA CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　上原　幸樹
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪市中央区高麗橋三丁目２番７号　ＯＲＩＸ高麗橋ビル

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass